By Trey Riley, Vice President, Solutions Engineering at Within3
Biotechs and small pharma companies are often at a disadvantage when trying to engage managed care executives for pre-approval information exchanges (PIE). These decision-makers receive an overwhelming number of requests and are selective about where they invest their time, especially when the therapeutic landscape is already crowded and product differentiation isn’t immediately obvious. For newer, less-established manufacturers with limited late-stage assets, building relationships and securing meetings can take six months to a year–valuable time that can impact launch readiness and market success.
That delay can prove costly. At this critical pre-launch stage, every insight, data point, and strategic advantage counts. Yet smaller organizations often face resource limitations, internal alignment challenges, and process inefficiencies that slow down their ability to prepare for high-impact PIE meetings.
Why differentiation and motivation matter more than ever
Today’s payers aren’t just evaluating clinical efficacy; they’re looking for meaningful differentiation and clear therapeutic reason to engage. In saturated therapeutic areas, where multiple drugs offer similar mechanisms of action or marginal benefits, convincing payers to schedule a PIE—or consider your product for formulary inclusion—requires more than a lengthy slide deck of scientific facts.
It requires a well-honed commercial profile built on:
- Comprehensive market and stakeholder intelligence
- Localized engagement strategies informed by insights from top local prescribers and thought leaders
- Evidence that aligns with both clinical and economic priorities
- A unified story told across commercial, medical, and regulatory functions
So, how can market access, payer marketing, and medical affairs teams elevate their approach and accelerate readiness?
Strategies to improve payer engagement and PIE outcomes
1. Start with unified, real-time market intelligence
Obtaining credible, up-to-date intelligence earlier in the development process—then sharing it across teams—can significantly improve decision-making. Look for platforms that aggregate internal and external data from multiple sources, including:
- Advisory board summaries
- Social listening
- Medical claims and real-world evidence
These insights enable teams to spot unmet needs, frame compelling differentiators, and respond quickly to shifts in the market: all before the PIE meeting is even requested.
Platforms that include these data streams natively also reduce costs and encourage collaboration across internal stakeholders (i.e. medical, commercial and clinical). Smaller manufacturers can spend significant budget dollars on multiple third-party vendors or bespoke consulting projects. A consolidated system eliminates that complexity while streamlining time-to-insight, at a lower budgetary impact.
2. Prioritize insights from the right KOLs
Don’t rely solely on the most published researchers. The most strategic voices for Market Access and Payer Marketing teams often include those with influence in HEOR, clinical guideline development, and payer advisory roles, especially in key geographies.
Look for platforms that objectively identify expert networks based on reach, influence, and peer connectivity. These “in the trenches” leaders offer feedback that not only validates data shared during the information exchange, but may also shape future trial design or highlight regional barriers to coverage.
3. Integrate patient and caregiver perspectives
Payer decision-making isn’t only about hard clinical endpoints. Patient and caregiver feedback provides important context that helps payers understand the real-world impact. These perspectives often surface needs not captured in HCP discussions, such as caregiver burden, lifestyle fit, or administration challenges.
Incorporating these voices into the asset’s value story strengthens the case for differentiation and adds credibility to the overall proposition.
4. Harvest competitive intelligence early and often
Understanding how payers perceive existing therapies helps your team proactively refine positioning. Ongoing competitive monitoring uncovers:
- Shifts in coverage criteria
- Messaging strategies of key competitors
- Gaps in evidence that your program can address
This allows your team to adjust content, messaging, or even trial endpoints to match market expectations.
5. Bridge commercial, medical, and regulatory perspectives
Aligning internal teams around PIE strategy is often harder than expected. Different functions may prioritize different data points, timelines, or risk tolerances. This misalignment can result in content gaps or delays—especially in highly scrutinized regulatory environments.
By investing in shared tools that support secure, compliant collaboration across teams, companies can unify around a single source of truth for payer engagement. This improves consistency and ensures all stakeholders—commercial, medical affairs, market access, and clinical development—are working from the same strategic playbook.
6. Prioritize user experience and insight accessibility
Even the most advanced intelligence platform won’t deliver value if it’s hard to use. Ensure your chosen tool makes it easy to:
- Visualize key trends
- Filter insights by source, geography, or sentiment
- Track emerging themes over time
User-friendly dashboards and streamlined workflows help teams focus on action, not navigation.
A faster, smarter path to PIE readiness
In a competitive launch environment, manufacturers can’t afford delays or missteps in payer engagement. The best “recipe” for PIE success is to deliver credible, current, and clearly differentiated value evidence, presented in a format that motivates healthcare decision-makers to act.
And just like any great recipe, it comes down to using the right ingredients in the right way:
- Real-time market intelligence from diverse data sources
- Strategic KOL insights with payer and HEOR influence
- Patient and caregiver perspectives to round out the value story
- Competitive intelligence to anticipate and adapt
- Aligned internal teams with shared access to insights
- User-friendly platforms that streamline collaboration and drive clarity
When these ingredients are blended together with the right timing and tools, the result is a compelling, payer-ready narrative that sets your product apart.
Ready to optimize your winning recipe for PIE and payer success?
Let Within3 help you source the right ingredients, refine your approach, and serve up a value story that resonates. We’ve supported all Top 20 global pharmaceutical companies—and we’re ready to help your team differentiate, align, and win.
